Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity
|
April 16, 2014
Practical treatment using mitotane for adrenocortical carcinoma
Massimo Terzolo, Barbara Zaggia, Barbara Allasino, et al.
European Urology
|
February 9, 2010
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer
Francesco Porpiglia, Cristian Fiori, Fulvia Daffara, et al.
International Journal of Endocrinology
|
June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal Adenomas
Giuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Human Pathology
|
December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma
Eleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Human Pathology
|
October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases
Eleonora Duregon, Marco Volante, Enrico Bollito, et al.
European Journal of Endocrinology
|
August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
Giuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology
|
August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Giuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Pharmacogenetics and Genomics
|
March 26, 2013
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
Antonio D'Avolio, Silvia De Francia, Vittoria Basile, et al.
Endocrine-Related Cancer
|
October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma
Alfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Opinion in Endocrinology, Diabetes, and Obesity
|
April 16, 2014
Practical treatment using mitotane for adrenocortical carcinoma
Massimo Terzolo, Barbara Zaggia, Barbara Allasino, et al.
European Urology
|
February 9, 2010
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer
Francesco Porpiglia, Cristian Fiori, Fulvia Daffara, et al.
International Journal of Endocrinology
|
June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal Adenomas
Giuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Human Pathology
|
December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma
Eleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Human Pathology
|
October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases
Eleonora Duregon, Marco Volante, Enrico Bollito, et al.
European Journal of Endocrinology
|
August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
Giuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology
|
August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Giuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Pharmacogenetics and Genomics
|
March 26, 2013
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
Antonio D'Avolio, Silvia De Francia, Vittoria Basile, et al.
Endocrine-Related Cancer
|
October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma
Alfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.
Page
of 2